Merck to buy Schering-Plough in $41 billion deal Reported by David Jolly Publ With the purchase, Merck is expanding its franchise in cardiovascular, respiratory and oncology drugs and shoring up its research pipeline, in particular with a Schering-Plough product called TRA, a … [Read more...] about Merck Puts Some of Their Gardasil Cash To Work
Inc.
Merck Execs See ‘Sage’ as Key Ingredient for Disease Biology
Will Open Source "SAGE" platform lead to more transperency to MERCK's research and clinical trials process?Consumers can only hope. Of course if MERCK corporate lawyers figure out that such an open source platform may lead to a clear chain of custody of the type of … [Read more...] about Merck Execs See ‘Sage’ as Key Ingredient for Disease Biology
Social Networking Sites Have Myriad Trial-Related Uses
The information in this post was gathered from an article published by Deb Bortifz in eCliniqua, Innovative Management in Clinical Trials. eCliniqua offers PodCasts, WebCasts, White Papers and much more. Their 'data-rich' site is one of my primary research resources for an … [Read more...] about Social Networking Sites Have Myriad Trial-Related Uses
NVIC Says Government Denies Gardasil Risks
Vaccine Watchdog Group Calls for Transparency WASHINGTON--(BUSINESS WIRE)--The National Vaccine Information Center (NVIC) is calling on the Centers for Disease Control (CDC) and Food and Drug Administration (FDA) to publicly release the study design, data and names of principal … [Read more...] about NVIC Says Government Denies Gardasil Risks
Supreme Court To Consider Federal Pre-Emption In Wyeth V. Levine
The U.S. Supreme Court next week will begin hearing the case of Wyeth v. Levine, which centers on the question of whether FDA approval of a drug warning label pre-empts product safety suits brought in state courts, the Wall Street Journal reports (Mundy/Wang, Wall Street Journal, … [Read more...] about Supreme Court To Consider Federal Pre-Emption In Wyeth V. Levine